Finally, the importance of eradicating the NPM1-mutated clone to achieve cure of AML is exemplified by the clinical observation of patients with NPM1-DNMT3A double-mutated AML after cessation of therapy. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.